Long-Term Outcomes of Two-port Non-vitrectomy Endolaser Therapy in Moderate-to-severe Stage 3A Coats Disease
Listen to this summary
The authors aimed to evaluate the long-term outcomes of two-port non-vitrectomy endolaser therapy (TPNVE) in patients with moderate-to-severe stage 3A Coats disease. The study found that TPNVE achieved anatomic success in all treated eyes, with a median of two treatment sessions required, and highlighted the occurrence of complications such as cataracts and vitreoretinal fibrosis. Notably, approximately half of the eyes with an extent of exudative retinal detachment of at least 4 clock hours achieved success after a single treatment session.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More in Ophthalmology
View all →Nov 20, 2026 · American journal of ophthalmology
Association of allergic conjunctivitis severity with meibomian gland abnormalities in children: a cross-sectional study.
Nov 19, 2026 · American journal of ophthalmology
Smoke, Not Smoking, as a Possible Risk Factor Triggering Conversion in Leber's Hereditary Optic Neuropathy: A Retrospective Case Series.
Nov 19, 2026 · American journal of ophthalmology
Historical Redlining and Present-Day Vision Disability in Atlanta, Georgia: The Mediating Role of Neighborhood Deprivation.
Nov 19, 2026 · Lancet (London, England)
Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Nov 19, 2026 · Lancet (London, England)
Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.
Nov 19, 2026 · Lancet (London, England)
Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


